Back to search
FDAFDA · Food and drugs·Recall number D-0865-2023

ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, Compounded by: Empower Pharmacy, 5980 W Sam Houston Pkwy N Ste 300 Houston, TX 77041, NDC 72627-2405-1

Published June 14, 2023 · Recall initiated: May 12, 2023

Summary

FDA records drug Class II recall D-0865-2023, published June 14, 2023 and initiated May 12, 2023. Recalling firm: Empower Clinic Services LLC dba Empower Pharmacy; Status: Completed; Reported quantity: 504 vials; Lot: Lot: 606775 BUD: 09/25/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Mislabeling: preservative free product labeled as preserved.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Empower Clinic Services LLC dba Empower Pharmacy
Distributor
Distributed Nationwide in the USA
Lot
Lot: 606775 BUD: 09/25/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, Compounded by: Empower Pharmacy, 5980 W Sam Houston Pkwy N Ste 300 Houston, TX 77041, NDC 72627-2405-1 recalled?

Yes. FDA published recall D-0865-2023 on June 14, 2023. Reported hazard: Mislabeling: preservative free product labeled as preserved.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail